Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2665-2673

  Leader, Avi ^a,b   Ayzenfeld, Racheli Heffez ^a,b   Lishner, Michael ^a,b   Cohen, Efrat ^c   Segev, David ^c   Hermoni, Doron ^b,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; MALE; OSTEOPOROTIC FRACTURES; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; THYROID FUNCTION TESTS; THYROTROPIN;

EID: 84905836983     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2474     Document Type: Article

References (36)

1. Robbins J. Factors altering thyroid hormone metabolism. Environ Health Perspect. 1981;38:65-70.
2. Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA. 1989;261(18):2653- 2655.
3. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med. 1995;11(2):159-169.
4. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroidantibodiesintheunitedstatespopulation(1988to1994):National healthandnutritionexaminationsurvey(NHANESIII). J Clin Endocrinol Metab. 2002;87(2):489-499.
5. Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(2):128-141.
6. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481-493.
7. Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115(2):151-162.
8. Murphy E, Williams GR. The thyroid and the skeleton. Clin Endocrinol (Oxf). 2004;61(3):285-298.
9. Gogakos AI, Duncan Bassett JH, Williams GR. Thyroid and bone. Arch Biochem Biophys. 2010;503(1):129-136.
10. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990;19(1):35-63.
11. TurnerMR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ. 2011;342:d2238.
12. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: A nationwide follow-up study in 16, 249 patients. Thyroid. 2002;12(5):411-419.
13. Lee JS, Buzková P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010; 170(21):1876-1883.
14. van der Deure WM, Uitterlinden AG, Hofman A, et al. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: The rotterdam study. Clin Endocrinol (Oxf). 2008; 68(2):175-181.
15. Mazziotti G, Porcelli T, Patelli I, Vescovi PP, Giustina A. SerumTSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone. 2010;46(3):747-751.
16. Murphy E, Glüer CC, Reid DM, et al. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab. 2010;95(7): 3173-3181.
17. Waring AC, Harrison S, Fink HA, et al; Osteoporotic Fractures in Men (MrOS) Study. A prospective study of thyroid function, bone loss, and fractures in older men: TheMrOSstudy. J Bone Miner Res. 2013;28(3):472-479.
18. Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES. Predictors of falls among postmenopausal women: Results from the national osteoporosis risk assessment (NORA). Osteoporos Int. 2009;20(5):715-722.
19. Khalili H, Huang ES, Jacobson BC, Camargo CA Jr, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 2012;344:e372.
20. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. study of osteoporotic fractures research group. N Engl J Med. 1995;332(12):767-773.
21. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis. Thyroid. 2003;13(6):585-593.
22. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001;345(7):512-516.
23. Wright NC, Saag KG, Curtis JR, et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res. 2012;27(11):2325- 2332.
24. Danielson ME, Beck TJ, Lian Y, et al. Ethnic variability in bone geometry as assessed by hip structure analysis: Findings from the hip strength across the menopausal transition study. J Bone Miner Res. 2013;28(4):771-779.
25. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M. Epidemiology of hip fractures. Bone. 1996;18(1 Suppl):57S- 63S.
26. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: The tromso study. Thyroid. 2008; 18(11):1147-1155.
27. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the united states, 2005-2025. J Bone Miner Res. 2007; 22(3):465-475.
28. Cheng SY, Levy AR, Lefaivre KA, Guy P, Kuramoto L, Sobolev B. Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int. 2011;22(10):2575-2586.
29. Robbins J, Aragaki AK, Kooperberg C, et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007; 298(20):2389-2398.
30. Durosier C, Hans D, Krieg MA, Schott AM. Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J Clin Densitom. 2006;9(4):475-495.
31. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385-397.
32. McCloskey E, Johansson H, Oden A, Kanis JA. Fracture risk assessment. Clin Biochem. 2012;45(12):887-893.
33. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1): 186-193.
34. Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: The HUNT study. Arch Intern Med. 2008;168(8):855-860.
35. Heeringa J, Hoogendoorn EH, van der Deure WM, et al. Highnormal thyroid function and risk of atrial fibrillation: The rotterdam study. Arch Intern Med. 2008;168(20):2219-2224.
36. Pereg D, Tirosh A, Elis A, et al. Mortality and coronary heart disease in euthyroid patients. Am J Med. 2012;125(8):826.e7-12.